2360487-93-8
Chemical Structure
Menin-MLL inhibitor 19
- CAS No.: 2360487-93-8
- Formula:C30H34F3N7O4S
- Molecular Weight:645.70
IUPAC Name: tert-butyl ((1-(2-amino-2-oxoethyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)methyl)(2-(6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)-2-azaspiro[3.4]octan-6-yl)carbamate
InChIKey: FUBBZUWVZBXTGJ-UHFFFAOYSA-N
SMILES: O=C(N(C1CCC2(C1)CN(C2)C3=C4C=C(CC(F)(F)F)SC4=NC=N3)CC5=CC=C6C(NC(N6CC(N)=O)=O)=C5)OC(C)(C)C
Biological Activity: Menin-MLL inhibitor 19, a potent exo-aza spiro inhibitor of menin-mll interaction, example A17, extracted from patent WO2019120209A1. Menin-MLL inhibitor 19 can be used for the reseaech of various diseases, such as cancer, myelodysplastic syndrome (MDS) and diabetes[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Menin-MLL inhibitor 19 | 98.32% | Menin-MLL inhibitor 19, a potent exo-aza spiro inhibitor of menin-mll interaction, example A17, extracted from patent WO2019120209A1. Menin-MLL inhibitor 19 can be used for the reseaech of various diseases, such as cancer, myelodysplastic syndrome (MDS) and diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
